Richmond biotech BrainBox Solutions Inc., the maker of an artificial intelligence-enabled concussion test, has earned a broad patent from the U.S. Patent and Trademark Office for a set of eight biomarkers that correlate to specific findings on MRI tests.
CEO Donna Edmonds said in a statement the biomarkers covered by the patent include indicators of specific brain dysfunction, “enabling objective assessments of longer-term injury risk and the need for further monitoring and diagnostic testing.”
The…
